Prevention of palmar–plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)
Author:
Funder
Swiss Group of Clinical Cancer Research
Spirig Pharma, Egerkingen
ESSEX Chemie AG Luzern
Swiss State Secretariat of Education and Research
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference20 articles.
1. Pegylated liposomal doxorubicin-related palmar–plantar erythrodysesthesia (‘hand–foot’ syndrome);Lorusso;Ann Oncol,2007
2. Chemotherapy-induced palmar–plantar erythrodysesthesia syndrome: etiology and emerging therapies;Clark;Support Cancer Ther,2004
3. Detection of doxorubicin in the horny layer in a patient suffering from palmar–plantar erythrodysaesthesia;Schmook;Dermatology,2005
4. Palmar–plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre;Webster-Gandy;Eur J Oncol Nurs,2007
5. Clinical presentation and management of hand–foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer;Gomez;Oncologist,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The validity of over-the-counter skin, hair, and nail recommendations for adult patients with cancer: A systematic review;Supportive Care in Cancer;2024-08-08
2. Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial;BMC Cancer;2023-05-04
3. Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-24
4. Hand–foot syndrome induced by chemotherapy drug;Indian Journal of Pharmacology;2022-05
5. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients;World Journal of Clinical Cases;2021-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3